Zentalis Pharmaceuticals: Late Stage, Lots Of Cash, Crushed By The Market

Zentalis Pharmaceuticals ( ZNTL ) is a microcap biotech developer of targeted therapies within the space of DNA damage repair. After a recent restructuring, they are focusing all effort on the late-stage development of one drug. However, theI have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do your due diligence and not ge ...